nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.122	0.178	CbGbCtD
Pioglitazone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0848	0.124	CbGbCtD
Pioglitazone—CYP2C8—Progesterone—uterine cancer	0.0805	0.118	CbGbCtD
Pioglitazone—CYP2C19—Progesterone—uterine cancer	0.0676	0.099	CbGbCtD
Pioglitazone—PTGS1—Etoposide—uterine cancer	0.0625	0.0915	CbGbCtD
Pioglitazone—CYP2C9—Progesterone—uterine cancer	0.0562	0.0823	CbGbCtD
Pioglitazone—CYP2D6—Progesterone—uterine cancer	0.0514	0.0752	CbGbCtD
Pioglitazone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0493	0.0722	CbGbCtD
Pioglitazone—CYP2C8—Etoposide—uterine cancer	0.036	0.0528	CbGbCtD
Pioglitazone—CYP3A4—Progesterone—uterine cancer	0.0327	0.0478	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—uterine cancer	0.0157	0.023	CbGbCtD
Pioglitazone—CYP3A4—Etoposide—uterine cancer	0.0146	0.0214	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—uterine cancer	0.00997	0.0146	CbGbCtD
Pioglitazone—PPARG—Teniposide—Etoposide—uterine cancer	0.00416	1	CbGdCrCtD
Pioglitazone—PPARG—artery—uterine cancer	0.00394	0.097	CbGeAlD
Pioglitazone—PTGS1—oviduct—uterine cancer	0.00318	0.0783	CbGeAlD
Pioglitazone—PTGS1—artery—uterine cancer	0.0021	0.0519	CbGeAlD
Pioglitazone—SLCO1B3—vagina—uterine cancer	0.00201	0.0496	CbGeAlD
Pioglitazone—SLCO1B1—renal system—uterine cancer	0.0016	0.0396	CbGeAlD
Pioglitazone—PPARG—epithelium—uterine cancer	0.00149	0.0368	CbGeAlD
Pioglitazone—PPARG—smooth muscle tissue—uterine cancer	0.00144	0.0355	CbGeAlD
Pioglitazone—PPARG—decidua—uterine cancer	0.00141	0.0348	CbGeAlD
Pioglitazone—PPARG—renal system—uterine cancer	0.00138	0.0341	CbGeAlD
Pioglitazone—PPARG—mammalian vulva—uterine cancer	0.00129	0.0319	CbGeAlD
Pioglitazone—SLCO1B1—female reproductive system—uterine cancer	0.00129	0.0317	CbGeAlD
Pioglitazone—PPARG—uterus—uterine cancer	0.00123	0.0304	CbGeAlD
Pioglitazone—PPARG—female reproductive system—uterine cancer	0.00111	0.0273	CbGeAlD
Pioglitazone—PPARG—female gonad—uterine cancer	0.00101	0.0249	CbGeAlD
Pioglitazone—PPARG—vagina—uterine cancer	0.001	0.0247	CbGeAlD
Pioglitazone—CYP2C8—renal system—uterine cancer	0.000913	0.0225	CbGeAlD
Pioglitazone—CYP2C8—endometrium—uterine cancer	0.000882	0.0218	CbGeAlD
Pioglitazone—PTGS1—epithelium—uterine cancer	0.000798	0.0197	CbGeAlD
Pioglitazone—PTGS1—uterine cervix—uterine cancer	0.000791	0.0195	CbGeAlD
Pioglitazone—PTGS1—smooth muscle tissue—uterine cancer	0.000769	0.019	CbGeAlD
Pioglitazone—CYP2C19—vagina—uterine cancer	0.000757	0.0187	CbGeAlD
Pioglitazone—PTGS1—renal system—uterine cancer	0.00074	0.0182	CbGeAlD
Pioglitazone—CYP2C8—female reproductive system—uterine cancer	0.000731	0.018	CbGeAlD
Pioglitazone—PTGS1—endometrium—uterine cancer	0.000715	0.0176	CbGeAlD
Pioglitazone—PTGS1—mammalian vulva—uterine cancer	0.000692	0.0171	CbGeAlD
Pioglitazone—Myalgia—Progesterone—uterine cancer	0.000675	0.00279	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00067	0.00277	CcSEcCtD
Pioglitazone—Discomfort—Progesterone—uterine cancer	0.000667	0.00276	CcSEcCtD
Pioglitazone—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000666	0.00276	CcSEcCtD
Pioglitazone—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000664	0.00275	CcSEcCtD
Pioglitazone—CYP2C8—vagina—uterine cancer	0.000661	0.0163	CbGeAlD
Pioglitazone—PTGS1—uterus—uterine cancer	0.000659	0.0163	CbGeAlD
Pioglitazone—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000656	0.00272	CcSEcCtD
Pioglitazone—CYP2C9—female reproductive system—uterine cancer	0.000649	0.016	CbGeAlD
Pioglitazone—PPARG—lymph node—uterine cancer	0.000649	0.016	CbGeAlD
Pioglitazone—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000648	0.00268	CcSEcCtD
Pioglitazone—Oedema—Progesterone—uterine cancer	0.000647	0.00268	CcSEcCtD
Pioglitazone—Anaphylactic shock—Progesterone—uterine cancer	0.000647	0.00268	CcSEcCtD
Pioglitazone—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000645	0.00267	CcSEcCtD
Pioglitazone—Hepatitis—Dactinomycin—uterine cancer	0.000644	0.00266	CcSEcCtD
Pioglitazone—Infection—Progesterone—uterine cancer	0.000643	0.00266	CcSEcCtD
Pioglitazone—Glycosuria—Epirubicin—uterine cancer	0.000642	0.00266	CcSEcCtD
Pioglitazone—Pharyngitis—Dactinomycin—uterine cancer	0.000639	0.00264	CcSEcCtD
Pioglitazone—Nervous system disorder—Progesterone—uterine cancer	0.000634	0.00263	CcSEcCtD
Pioglitazone—Skin disorder—Progesterone—uterine cancer	0.000628	0.0026	CcSEcCtD
Pioglitazone—Hyperhidrosis—Progesterone—uterine cancer	0.000625	0.00259	CcSEcCtD
Pioglitazone—CYP3A4—renal system—uterine cancer	0.000618	0.0152	CbGeAlD
Pioglitazone—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00253	CcSEcCtD
Pioglitazone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00253	CcSEcCtD
Pioglitazone—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00253	CcSEcCtD
Pioglitazone—CYP2D6—renal system—uterine cancer	0.000608	0.015	CbGeAlD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.00251	CcSEcCtD
Pioglitazone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000604	0.0025	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Etoposide—uterine cancer	0.000594	0.00246	CcSEcCtD
Pioglitazone—Glycosuria—Doxorubicin—uterine cancer	0.000594	0.00246	CcSEcCtD
Pioglitazone—PTGS1—female reproductive system—uterine cancer	0.000593	0.0146	CbGeAlD
Pioglitazone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000589	0.00244	CcSEcCtD
Pioglitazone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00243	CcSEcCtD
Pioglitazone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00243	CcSEcCtD
Pioglitazone—Insomnia—Progesterone—uterine cancer	0.000585	0.00242	CcSEcCtD
Pioglitazone—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000582	0.00241	CcSEcCtD
Pioglitazone—Dyspnoea—Progesterone—uterine cancer	0.000577	0.00239	CcSEcCtD
Pioglitazone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00238	CcSEcCtD
Pioglitazone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000569	0.00236	CcSEcCtD
Pioglitazone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000567	0.00235	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000559	0.00231	CcSEcCtD
Pioglitazone—Fatigue—Progesterone—uterine cancer	0.000558	0.00231	CcSEcCtD
Pioglitazone—PTGS1—female gonad—uterine cancer	0.000539	0.0133	CbGeAlD
Pioglitazone—PTGS1—vagina—uterine cancer	0.000536	0.0132	CbGeAlD
Pioglitazone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000534	0.00221	CcSEcCtD
Pioglitazone—Feeling abnormal—Progesterone—uterine cancer	0.000533	0.00221	CcSEcCtD
Pioglitazone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00053	0.0022	CcSEcCtD
Pioglitazone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000523	0.00216	CcSEcCtD
Pioglitazone—Ill-defined disorder—Dactinomycin—uterine cancer	0.00052	0.00215	CcSEcCtD
Pioglitazone—Infestation NOS—Etoposide—uterine cancer	0.000519	0.00215	CcSEcCtD
Pioglitazone—Infestation—Etoposide—uterine cancer	0.000519	0.00215	CcSEcCtD
Pioglitazone—Anaemia—Dactinomycin—uterine cancer	0.000518	0.00214	CcSEcCtD
Pioglitazone—Urticaria—Progesterone—uterine cancer	0.000514	0.00213	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Etoposide—uterine cancer	0.000512	0.00212	CcSEcCtD
Pioglitazone—Myocardial infarction—Etoposide—uterine cancer	0.000509	0.00211	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.0021	CcSEcCtD
Pioglitazone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000505	0.00209	CcSEcCtD
Pioglitazone—Malaise—Dactinomycin—uterine cancer	0.000505	0.00209	CcSEcCtD
Pioglitazone—CYP3A4—female reproductive system—uterine cancer	0.000495	0.0122	CbGeAlD
Pioglitazone—Fluid retention—Epirubicin—uterine cancer	0.000494	0.00204	CcSEcCtD
Pioglitazone—CYP2D6—female reproductive system—uterine cancer	0.000487	0.012	CbGeAlD
Pioglitazone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000483	0.002	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Epirubicin—uterine cancer	0.000478	0.00198	CcSEcCtD
Pioglitazone—Myalgia—Dactinomycin—uterine cancer	0.000477	0.00197	CcSEcCtD
Pioglitazone—Hypersensitivity—Progesterone—uterine cancer	0.000477	0.00197	CcSEcCtD
Pioglitazone—Discomfort—Dactinomycin—uterine cancer	0.000471	0.00195	CcSEcCtD
Pioglitazone—Neoplasm—Epirubicin—uterine cancer	0.00047	0.00195	CcSEcCtD
Pioglitazone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000466	0.00193	CcSEcCtD
Pioglitazone—Asthenia—Progesterone—uterine cancer	0.000464	0.00192	CcSEcCtD
Pioglitazone—Hypoaesthesia—Etoposide—uterine cancer	0.000463	0.00192	CcSEcCtD
Pioglitazone—Pulmonary oedema—Epirubicin—uterine cancer	0.000463	0.00192	CcSEcCtD
Pioglitazone—Urinary tract disorder—Etoposide—uterine cancer	0.00046	0.0019	CcSEcCtD
Pioglitazone—Oedema—Dactinomycin—uterine cancer	0.000457	0.00189	CcSEcCtD
Pioglitazone—Fluid retention—Doxorubicin—uterine cancer	0.000457	0.00189	CcSEcCtD
Pioglitazone—Urethral disorder—Etoposide—uterine cancer	0.000457	0.00189	CcSEcCtD
Pioglitazone—Infection—Dactinomycin—uterine cancer	0.000454	0.00188	CcSEcCtD
Pioglitazone—Abnormal vision—Epirubicin—uterine cancer	0.000453	0.00188	CcSEcCtD
Pioglitazone—CYP2D6—female gonad—uterine cancer	0.000443	0.0109	CbGeAlD
Pioglitazone—Diarrhoea—Progesterone—uterine cancer	0.000443	0.00183	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000442	0.00183	CcSEcCtD
Pioglitazone—Eye disorder—Etoposide—uterine cancer	0.000435	0.0018	CcSEcCtD
Pioglitazone—Neoplasm—Doxorubicin—uterine cancer	0.000435	0.0018	CcSEcCtD
Pioglitazone—Diabetes mellitus—Epirubicin—uterine cancer	0.000434	0.0018	CcSEcCtD
Pioglitazone—Cardiac disorder—Etoposide—uterine cancer	0.000432	0.00179	CcSEcCtD
Pioglitazone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000432	0.00179	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—uterine cancer	0.000428	0.00177	CcSEcCtD
Pioglitazone—Dizziness—Progesterone—uterine cancer	0.000428	0.00177	CcSEcCtD
Pioglitazone—Immune system disorder—Etoposide—uterine cancer	0.000421	0.00174	CcSEcCtD
Pioglitazone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000421	0.00174	CcSEcCtD
Pioglitazone—Hepatic failure—Epirubicin—uterine cancer	0.00042	0.00174	CcSEcCtD
Pioglitazone—Mediastinal disorder—Etoposide—uterine cancer	0.00042	0.00174	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—uterine cancer	0.00042	0.00174	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000417	0.00172	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Epirubicin—uterine cancer	0.000416	0.00172	CcSEcCtD
Pioglitazone—Headache—Progesterone—uterine cancer	0.000405	0.00168	CcSEcCtD
Pioglitazone—Increased appetite—Epirubicin—uterine cancer	0.000402	0.00166	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—uterine cancer	0.000402	0.00166	CcSEcCtD
Pioglitazone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.00166	CcSEcCtD
Pioglitazone—Fatigue—Dactinomycin—uterine cancer	0.000394	0.00163	CcSEcCtD
Pioglitazone—Back pain—Etoposide—uterine cancer	0.000392	0.00162	CcSEcCtD
Pioglitazone—Muscle spasms—Etoposide—uterine cancer	0.00039	0.00161	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—uterine cancer	0.000389	0.00161	CcSEcCtD
Pioglitazone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000388	0.0016	CcSEcCtD
Pioglitazone—Hypoglycaemia—Epirubicin—uterine cancer	0.000387	0.0016	CcSEcCtD
Pioglitazone—Cardiac failure—Epirubicin—uterine cancer	0.000387	0.0016	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Epirubicin—uterine cancer	0.000385	0.00159	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000385	0.00159	CcSEcCtD
Pioglitazone—Pain in extremity—Epirubicin—uterine cancer	0.000377	0.00156	CcSEcCtD
Pioglitazone—Feeling abnormal—Dactinomycin—uterine cancer	0.000377	0.00156	CcSEcCtD
Pioglitazone—Ill-defined disorder—Etoposide—uterine cancer	0.000376	0.00156	CcSEcCtD
Pioglitazone—Anaemia—Etoposide—uterine cancer	0.000375	0.00155	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—uterine cancer	0.000372	0.00154	CcSEcCtD
Pioglitazone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000367	0.00152	CcSEcCtD
Pioglitazone—Malaise—Etoposide—uterine cancer	0.000366	0.00151	CcSEcCtD
Pioglitazone—Vertigo—Etoposide—uterine cancer	0.000364	0.00151	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—uterine cancer	0.000358	0.00148	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—uterine cancer	0.000358	0.00148	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000356	0.00148	CcSEcCtD
Pioglitazone—Hypertension—Etoposide—uterine cancer	0.00035	0.00145	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—uterine cancer	0.000349	0.00145	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—uterine cancer	0.000348	0.00144	CcSEcCtD
Pioglitazone—PTGS1—lymph node—uterine cancer	0.000347	0.00855	CbGeAlD
Pioglitazone—Chest pain—Etoposide—uterine cancer	0.000345	0.00143	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—uterine cancer	0.000345	0.00143	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000343	0.00142	CcSEcCtD
Pioglitazone—Discomfort—Etoposide—uterine cancer	0.000341	0.00141	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—uterine cancer	0.000341	0.00141	CcSEcCtD
Pioglitazone—Hypersensitivity—Dactinomycin—uterine cancer	0.000337	0.00139	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000333	0.00138	CcSEcCtD
Pioglitazone—Anaphylactic shock—Etoposide—uterine cancer	0.000331	0.00137	CcSEcCtD
Pioglitazone—Infection—Etoposide—uterine cancer	0.000329	0.00136	CcSEcCtD
Pioglitazone—Asthenia—Dactinomycin—uterine cancer	0.000328	0.00136	CcSEcCtD
Pioglitazone—Influenza—Epirubicin—uterine cancer	0.000326	0.00135	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—uterine cancer	0.000322	0.00133	CcSEcCtD
Pioglitazone—Skin disorder—Etoposide—uterine cancer	0.000321	0.00133	CcSEcCtD
Pioglitazone—Hyperhidrosis—Etoposide—uterine cancer	0.00032	0.00132	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—uterine cancer	0.000319	0.00132	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—uterine cancer	0.000318	0.00132	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—uterine cancer	0.000316	0.00131	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—uterine cancer	0.000314	0.0013	CcSEcCtD
Pioglitazone—Diarrhoea—Dactinomycin—uterine cancer	0.000313	0.0013	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000308	0.00128	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000303	0.00126	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—uterine cancer	0.000302	0.00125	CcSEcCtD
Pioglitazone—Weight increased—Epirubicin—uterine cancer	0.000297	0.00123	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—uterine cancer	0.000295	0.00122	CcSEcCtD
Pioglitazone—Dyspnoea—Etoposide—uterine cancer	0.000295	0.00122	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—uterine cancer	0.000294	0.00122	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—uterine cancer	0.000294	0.00122	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—uterine cancer	0.000291	0.0012	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—uterine cancer	0.000291	0.0012	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—uterine cancer	0.00029	0.0012	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000286	0.00118	CcSEcCtD
Pioglitazone—Fatigue—Etoposide—uterine cancer	0.000285	0.00118	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—uterine cancer	0.000283	0.00117	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000281	0.00116	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—uterine cancer	0.000279	0.00115	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—uterine cancer	0.000277	0.00115	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—uterine cancer	0.000275	0.00114	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—uterine cancer	0.000273	0.00113	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—uterine cancer	0.000273	0.00113	CcSEcCtD
Pioglitazone—Feeling abnormal—Etoposide—uterine cancer	0.000273	0.00113	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—uterine cancer	0.000272	0.00113	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—uterine cancer	0.000269	0.00111	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—uterine cancer	0.000269	0.00111	CcSEcCtD
Pioglitazone—Urticaria—Etoposide—uterine cancer	0.000263	0.00109	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—uterine cancer	0.000262	0.00108	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—uterine cancer	0.000261	0.00108	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—uterine cancer	0.00026	0.00108	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—uterine cancer	0.000259	0.00107	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—uterine cancer	0.000258	0.00107	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—uterine cancer	0.000258	0.00107	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—uterine cancer	0.000257	0.00106	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—uterine cancer	0.000257	0.00106	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—uterine cancer	0.000257	0.00106	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—uterine cancer	0.000256	0.00106	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—uterine cancer	0.000252	0.00105	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—uterine cancer	0.000252	0.00104	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—uterine cancer	0.000244	0.00101	CcSEcCtD
Pioglitazone—Hypersensitivity—Etoposide—uterine cancer	0.000244	0.00101	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—uterine cancer	0.000242	0.001	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—uterine cancer	0.000242	0.001	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—uterine cancer	0.00024	0.000995	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—uterine cancer	0.00024	0.000993	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000239	0.000988	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—uterine cancer	0.000238	0.000985	CcSEcCtD
Pioglitazone—Asthenia—Etoposide—uterine cancer	0.000237	0.000983	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000237	0.000983	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—uterine cancer	0.000237	0.00098	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—uterine cancer	0.000236	0.000976	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—uterine cancer	0.000235	0.000974	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—uterine cancer	0.000233	0.000964	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—uterine cancer	0.000227	0.000941	CcSEcCtD
Pioglitazone—Diarrhoea—Etoposide—uterine cancer	0.000226	0.000937	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—uterine cancer	0.000226	0.000935	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—uterine cancer	0.000224	0.000928	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—uterine cancer	0.000224	0.000927	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—uterine cancer	0.00022	0.00091	CcSEcCtD
Pioglitazone—Dizziness—Etoposide—uterine cancer	0.000219	0.000906	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—uterine cancer	0.000219	0.000905	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—uterine cancer	0.000218	0.000903	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000218	0.000901	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—uterine cancer	0.000211	0.000873	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—uterine cancer	0.00021	0.000871	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—uterine cancer	0.00021	0.00087	CcSEcCtD
Pioglitazone—Headache—Etoposide—uterine cancer	0.000207	0.000858	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—uterine cancer	0.000207	0.000858	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—uterine cancer	0.000205	0.000849	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—uterine cancer	0.000204	0.000845	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—uterine cancer	0.000203	0.000842	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—uterine cancer	0.000202	0.000837	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—uterine cancer	0.000196	0.000812	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000195	0.000808	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—uterine cancer	0.000194	0.000805	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—uterine cancer	0.000194	0.000801	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—uterine cancer	0.000194	0.000801	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—uterine cancer	0.000194	0.000801	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000192	0.000796	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—uterine cancer	0.000191	0.000792	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—uterine cancer	0.00019	0.000785	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—uterine cancer	0.000189	0.000782	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—uterine cancer	0.000186	0.000768	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—uterine cancer	0.000186	0.000768	CcSEcCtD
Pioglitazone—Infection—Epirubicin—uterine cancer	0.000184	0.000763	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—uterine cancer	0.000182	0.000753	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—uterine cancer	0.000182	0.000752	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—uterine cancer	0.00018	0.000746	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—uterine cancer	0.000179	0.000742	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—uterine cancer	0.000179	0.000741	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—uterine cancer	0.000179	0.000741	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—uterine cancer	0.000179	0.000741	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000178	0.000736	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—uterine cancer	0.000177	0.000732	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—uterine cancer	0.000172	0.000711	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—uterine cancer	0.000172	0.000711	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—uterine cancer	0.000171	0.000706	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000169	0.0007	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—uterine cancer	0.000168	0.000697	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—uterine cancer	0.000168	0.000695	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—uterine cancer	0.000167	0.00069	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—uterine cancer	0.000166	0.000687	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—uterine cancer	0.000165	0.000685	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00016	0.000663	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—uterine cancer	0.00016	0.000662	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000156	0.000647	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—uterine cancer	0.000155	0.000643	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—uterine cancer	0.000153	0.000634	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—uterine cancer	0.000153	0.000633	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000148	0.000613	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—uterine cancer	0.000148	0.000613	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—uterine cancer	0.000147	0.00061	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—uterine cancer	0.000141	0.000586	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—uterine cancer	0.000137	0.000566	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—uterine cancer	0.000136	0.000565	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—uterine cancer	0.000133	0.000551	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—uterine cancer	0.000127	0.000525	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—uterine cancer	0.000126	0.000524	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—uterine cancer	0.000123	0.00051	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—uterine cancer	0.000123	0.000508	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—uterine cancer	0.000117	0.000486	CcSEcCtD
Pioglitazone—Headache—Epirubicin—uterine cancer	0.000116	0.000481	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—uterine cancer	0.000114	0.00047	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—uterine cancer	0.000108	0.000445	CcSEcCtD
Pioglitazone—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	7.36e-05	0.00238	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	7.26e-05	0.00235	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.25e-05	0.00234	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—ESR2—uterine cancer	7.24e-05	0.00234	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	7.2e-05	0.00233	CbGpPWpGaD
Pioglitazone—PPARG—SREBP signalling—AKT1—uterine cancer	7.2e-05	0.00233	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	7.16e-05	0.00231	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	7.1e-05	0.00229	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.09e-05	0.00229	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.01e-05	0.00226	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	6.77e-05	0.00219	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	6.71e-05	0.00217	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.58e-05	0.00212	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—STAR—uterine cancer	6.55e-05	0.00212	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKR1B1—uterine cancer	6.55e-05	0.00212	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	6.51e-05	0.0021	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.48e-05	0.00209	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.45e-05	0.00208	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	6.42e-05	0.00207	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.39e-05	0.00206	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NDUFB11—uterine cancer	6.09e-05	0.00197	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SRD5A2—uterine cancer	6.09e-05	0.00197	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.91e-05	0.00191	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—CDKN2B—uterine cancer	5.89e-05	0.0019	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	5.81e-05	0.00188	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	5.75e-05	0.00186	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	5.73e-05	0.00185	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.68e-05	0.00183	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.68e-05	0.00183	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKR1B1—uterine cancer	5.59e-05	0.00181	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—STAR—uterine cancer	5.59e-05	0.00181	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.58e-05	0.0018	CbGpPWpGaD
Pioglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	5.53e-05	0.00179	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.52e-05	0.00178	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NDUFB11—uterine cancer	5.42e-05	0.00175	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SRD5A2—uterine cancer	5.42e-05	0.00175	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—SMAD3—uterine cancer	5.38e-05	0.00174	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	5.34e-05	0.00173	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—PTEN—uterine cancer	5.31e-05	0.00172	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	5.3e-05	0.00171	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	5.27e-05	0.0017	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.26e-05	0.0017	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	5.23e-05	0.00169	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—POLD1—uterine cancer	5.14e-05	0.00166	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.07e-05	0.00164	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.07e-05	0.00164	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—EP300—uterine cancer	5.06e-05	0.00164	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—SMAD3—uterine cancer	5.06e-05	0.00164	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.04e-05	0.00163	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.97e-05	0.0016	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKR1C1—uterine cancer	4.81e-05	0.00155	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.75e-05	0.00153	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.68e-05	0.00151	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.62e-05	0.00149	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.62e-05	0.00149	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.42e-05	0.00143	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKR1B1—uterine cancer	4.4e-05	0.00142	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—STAR—uterine cancer	4.4e-05	0.00142	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—ESR1—uterine cancer	4.39e-05	0.00142	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—POLD1—uterine cancer	4.39e-05	0.00142	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.35e-05	0.00141	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—RRM2—uterine cancer	4.29e-05	0.00138	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.17e-05	0.00135	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—DCN—uterine cancer	4.16e-05	0.00134	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MET—uterine cancer	4.15e-05	0.00134	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKR1C1—uterine cancer	4.1e-05	0.00133	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PGR—uterine cancer	3.96e-05	0.00128	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP11A1—uterine cancer	3.92e-05	0.00127	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—STAR—uterine cancer	3.92e-05	0.00126	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKR1B1—uterine cancer	3.92e-05	0.00126	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.87e-05	0.00125	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—EZH2—uterine cancer	3.76e-05	0.00121	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.72e-05	0.0012	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKR1C3—uterine cancer	3.7e-05	0.0012	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—RRM2—uterine cancer	3.66e-05	0.00118	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TP53—uterine cancer	3.62e-05	0.00117	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—DCN—uterine cancer	3.55e-05	0.00115	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.5e-05	0.00113	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.5e-05	0.00113	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.49e-05	0.00113	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ESR2—uterine cancer	3.48e-05	0.00113	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—POLD1—uterine cancer	3.45e-05	0.00112	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.45e-05	0.00111	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.4e-05	0.0011	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.39e-05	0.0011	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP11A1—uterine cancer	3.34e-05	0.00108	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKR1C1—uterine cancer	3.23e-05	0.00104	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.21e-05	0.00104	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKR1C3—uterine cancer	3.16e-05	0.00102	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.12e-05	0.00101	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.12e-05	0.00101	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—POLD1—uterine cancer	3.07e-05	0.000992	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.03e-05	0.00098	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—ERBB2—uterine cancer	3.03e-05	0.00098	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP19A1—uterine cancer	2.88e-05	0.000931	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—STK11—uterine cancer	2.88e-05	0.000931	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—RRM2—uterine cancer	2.88e-05	0.00093	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKR1C1—uterine cancer	2.87e-05	0.000928	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.87e-05	0.000928	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.87e-05	0.000928	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.86e-05	0.000925	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.85e-05	0.00092	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.85e-05	0.00092	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—CDKN2B—uterine cancer	2.84e-05	0.000916	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—DCN—uterine cancer	2.8e-05	0.000903	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.77e-05	0.000893	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.71e-05	0.000874	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—CTNNB1—uterine cancer	2.65e-05	0.000857	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.63e-05	0.000851	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.61e-05	0.000844	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—SMAD3—uterine cancer	2.59e-05	0.000837	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.58e-05	0.000834	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—RRM2—uterine cancer	2.56e-05	0.000827	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.53e-05	0.000817	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—STAR—uterine cancer	2.53e-05	0.000817	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.5e-05	0.000808	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.49e-05	0.000803	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—DCN—uterine cancer	2.49e-05	0.000803	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EP300—uterine cancer	2.47e-05	0.000797	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—STK11—uterine cancer	2.46e-05	0.000795	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP19A1—uterine cancer	2.46e-05	0.000795	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP11A1—uterine cancer	2.34e-05	0.000757	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VEGFA—uterine cancer	2.34e-05	0.000755	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.31e-05	0.000746	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—NRAS—uterine cancer	2.31e-05	0.000745	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.26e-05	0.000729	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—STAR—uterine cancer	2.26e-05	0.000729	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.23e-05	0.000721	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKR1C3—uterine cancer	2.21e-05	0.000715	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.2e-05	0.000711	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—MTHFR—uterine cancer	2.17e-05	0.0007	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ESR1—uterine cancer	2.11e-05	0.000683	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.08e-05	0.000671	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—STAR—uterine cancer	2.08e-05	0.000671	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.06e-05	0.000665	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—STAR—uterine cancer	2.06e-05	0.000665	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.03e-05	0.000657	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—KRAS—uterine cancer	1.99e-05	0.000641	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—POLD1—uterine cancer	1.98e-05	0.000641	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.94e-05	0.000626	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—STK11—uterine cancer	1.94e-05	0.000626	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.91e-05	0.000617	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.88e-05	0.000607	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.88e-05	0.000607	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.86e-05	0.0006	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—MTHFR—uterine cancer	1.85e-05	0.000597	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.82e-05	0.000587	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—POLD1—uterine cancer	1.77e-05	0.000572	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.73e-05	0.00056	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—STK11—uterine cancer	1.72e-05	0.000557	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP19A1—uterine cancer	1.72e-05	0.000557	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—HRAS—uterine cancer	1.69e-05	0.000545	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.66e-05	0.000535	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—RRM2—uterine cancer	1.65e-05	0.000534	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.63e-05	0.000526	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—POLD1—uterine cancer	1.63e-05	0.000526	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.62e-05	0.000523	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—POLD1—uterine cancer	1.62e-05	0.000522	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—DCN—uterine cancer	1.61e-05	0.000519	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.54e-05	0.000498	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.52e-05	0.000492	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.51e-05	0.000489	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.51e-05	0.000488	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—uterine cancer	1.49e-05	0.000481	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—RRM2—uterine cancer	1.48e-05	0.000477	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.46e-05	0.00047	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—DCN—uterine cancer	1.43e-05	0.000463	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.43e-05	0.000462	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—RRM2—uterine cancer	1.36e-05	0.000439	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.36e-05	0.000438	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—STAR—uterine cancer	1.36e-05	0.000438	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.35e-05	0.000436	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—RRM2—uterine cancer	1.35e-05	0.000435	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—DCN—uterine cancer	1.32e-05	0.000426	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—DCN—uterine cancer	1.31e-05	0.000422	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MTHFR—uterine cancer	1.3e-05	0.000418	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.28e-05	0.000414	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.28e-05	0.000412	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.24e-05	0.000401	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.23e-05	0.000398	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—uterine cancer	1.21e-05	0.000389	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.17e-05	0.000379	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.16e-05	0.000376	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—EP300—uterine cancer	1.15e-05	0.000371	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.14e-05	0.000369	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—STK11—uterine cancer	1.11e-05	0.00036	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.11e-05	0.00036	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—POLD1—uterine cancer	1.07e-05	0.000344	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.05e-05	0.000338	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—uterine cancer	1.03e-05	0.000332	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.97e-06	0.000322	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.96e-06	0.000322	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—STK11—uterine cancer	9.94e-06	0.000321	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP19A1—uterine cancer	9.94e-06	0.000321	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—EP300—uterine cancer	9.81e-06	0.000317	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.33e-06	0.000301	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—STK11—uterine cancer	9.14e-06	0.000295	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP19A1—uterine cancer	9.14e-06	0.000295	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—STK11—uterine cancer	9.06e-06	0.000293	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP19A1—uterine cancer	9.06e-06	0.000293	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.9e-06	0.000287	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RRM2—uterine cancer	8.88e-06	0.000287	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—DCN—uterine cancer	8.62e-06	0.000278	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.51e-06	0.000275	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—uterine cancer	8.5e-06	0.000275	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—uterine cancer	8.37e-06	0.00027	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.12e-06	0.000262	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.11e-06	0.000262	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—uterine cancer	8.1e-06	0.000262	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—EP300—uterine cancer	7.72e-06	0.00025	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.67e-06	0.000248	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—uterine cancer	7.62e-06	0.000246	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—uterine cancer	7.47e-06	0.000241	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.37e-06	0.000238	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—uterine cancer	7.26e-06	0.000234	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—uterine cancer	7.21e-06	0.000233	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—uterine cancer	6.95e-06	0.000224	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—EP300—uterine cancer	6.87e-06	0.000222	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—uterine cancer	6.87e-06	0.000222	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—uterine cancer	6.81e-06	0.00022	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.58e-06	0.000213	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6e-06	0.000194	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.98e-06	0.000193	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—STK11—uterine cancer	5.98e-06	0.000193	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—uterine cancer	5.93e-06	0.000191	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—uterine cancer	5.71e-06	0.000185	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—uterine cancer	5.08e-06	0.000164	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—uterine cancer	4.67e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—uterine cancer	4.65e-06	0.00015	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—uterine cancer	4.49e-06	0.000145	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—EP300—uterine cancer	4.44e-06	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—uterine cancer	4.15e-06	0.000134	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—uterine cancer	4.15e-06	0.000134	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—EP300—uterine cancer	3.96e-06	0.000128	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—uterine cancer	3.82e-06	0.000123	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—uterine cancer	3.79e-06	0.000122	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—EP300—uterine cancer	3.64e-06	0.000118	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—EP300—uterine cancer	3.61e-06	0.000117	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.28e-06	0.000106	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.93e-06	9.47e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.7e-06	8.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—uterine cancer	2.68e-06	8.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.67e-06	8.63e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—uterine cancer	2.5e-06	8.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—uterine cancer	2.39e-06	7.73e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—EP300—uterine cancer	2.38e-06	7.7e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—uterine cancer	2.2e-06	7.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—uterine cancer	2.18e-06	7.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.76e-06	5.69e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—uterine cancer	1.44e-06	4.65e-05	CbGpPWpGaD
